Cardiac myosin inhibitor sustainably reduces LVOT gradient in HCM - PACE-CME

Cardiac myosin inhibitor sustainably reduces LVOT gradient in HCM

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Recommended

What are the challenges in making the right diagnosis in HCM?
What are the challenges in making the right diagnosis in HCM?
MinuteCE®
What are the challenges in making the right diagnosis in HCM?
0.75 program credits
- Perry Elliott, MD
0.75 program credits
Understanding the etiology of HCM and pathways for intervention
Understanding the etiology of HCM and pathways for intervention
MinuteCE®
Understanding the etiology of HCM and pathways for intervention
0.75 program credits
- Roberto Barriales-Villa, MD, PhD
0.75 program credits
The clinical challenge of managing a patient with HCM
The clinical challenge of managing a patient with HCM
MinuteCE®
The clinical challenge of managing a patient with HCM
0.75 program credits
- Iacopo Olivotto, MD
0.75 program credits
MinuteCE®
Navigating therapeutic approaches in HCM: Unravelling recent evidence
0.75 credits 4 episodes
- Perry Elliott, MD
- Ahmad Masri, MD, MS
- Roberto Barriales-Villa, MD, PhD
- Caroline Coats, MD
0.75 credits 4 episodes